M3GAN 2.0: A Case Study in AI Ethics and Policy

By Ambria Williams, Lisa Kearns, and Kellie Owens This piece contains spoilers for the films “M3GAN” and “M3GAN 2.0”. Imagine a science fiction horror movie with an ethicist as the protagonist. As improbable as that seems, it’s the case in M3GAN 2.0, the sequel to the 2023 box-office hit M3GAN, in which an AI tech […]

Read More…

Examining Norms in Medical & Scientific Communications amid Rapidly Advancing Technologies

By Rafael Escandon A recent social media posting got my attention for a couple of reasons. First, because it is quite unusual and second, because the detail behind the headline tells a different story than the headline suggests. This was the first posting since the advent of social media where I have seen a company […]

Read More…

Unequal access to reprogenetic cognitive enhancement due to consistently high costs

By Alexis Heng Boon Chin and Sayyed Mohamed Muhsin. A survey study by Haining et al. reported a significantly higher approval rating of human cognitive enhancement with reprogenetic technologies such as polygenic embryo screening and germline gene editing among Singaporean versus American respondents. The intensely competitive educational landscape in East Asian Confucian societies such as Singapore is […]

Read More…

Developing a practical resource to improve the ethical standing of gene therapy trials

By Rosie Munday, Hugh Davies and Stephanie Jones with Oxford “A” Health Research Authority Research Ethics Committee Oxford “A” NHS REC is one of the four UK Research Ethics Committees flagged to review gene therapy proposals. Following the philosopher Mary Warnock’s sage advice “I do not believe you can make moral judgements unless, as far […]

Read More…

Medical assistance in dying—is there a case for including persons with mental illness?

By Nicholas Delva, Anees Bahji Over the last couple of decades, medical assistance in dying (MAiD) has become legal in a few developed countries. Developments in this area have been primarily driven by patients, with general support from the population. Governments have been cautious in the development of legislation, which is not surprising given that […]

Read More…